Innovation by DRG at the 2016 AACC Convention
We sat down with top members of the DRG International team at the AACC Convention 2016 in Philadelphia, PA, US and discuss innovation in the diagnostic testing field.
Wilhelm Saenger (full profile)
Of course, for a small company like DRG that is the most important part. That they always have an eye on new technologies, on new products, including, of course, people which are motivated; motivated to work with DRG. To get new ideas … What is the direction that you can develop new products, new ELISAS. This is what makes DRG. We are very flexible. We find some ideas and it takes not very long to create the product from this idea and to enter the market with this product. It is what DRG makes: motivated people and good ideas for interesting products.
Michael Martini (full profile)
Example of what we’re doing currently. You’ll see, in the community, is the DRG Hybrid XL. This is really an advancement in the way analyzers work. You can do clinical chemistry and immunology with the same sample. It’s a CE marked machine. Currently selling it in the EU, the Middle East, Latin America, Canada and we’ll be launching in the US soon. This is what we’re doing to keep ahead of our … Advance the world of ELISAS and stay ahead of our competition.
Dr. Witold Jurkiewicz (full profile)
We are looking around. We have very well R&D office in Marburg, Germany. Where we are developing and creating new products; mostly agent kits. We are attending in many world exhibition meetings. We have excellent relations with our customer, with our university staff. All such messages… things help us and make us better with innovation of new products.
DRG has a very long history with core business. 40 years now. What’s important is we’ve taken this experience and transferred this to new technologies. With the hybrid projects, we are trying to create new niche products, new niche areas.
Dr. Oleg Vishnevski
In my opinion, we are one of the leaders on the market. Especially with the innovation of the Hybrid XL. We are probably the only company that makes their compact, non-expensive devices with FDA compliance. We utilize in the bar coding reader on the samples on the cartridges on the test itself.
Dr. Cyril E. Geacintov (full profile)
I call myself sometimes a renegade scientist because always have the drive to not just take something over, but to, so to speak, invent something. I’m probably a ridiculous optimist, because I always think, well, I could do it. Somebody in my company can do it. My intention has always been to not stop and do just what we know, but see if there’s a solution. If there’s another way of doing it. If I can develop something that is different. This is why DRG continues all the time to come up with new products, new equipment, new systems. It’s in me to go out and develop. The people I would like to have working with me, I want them also to think about how to best find a solution for a problem. Sometimes you buy it, sometimes you develop it. Of course, you cannot develop everything, but we try.
Latest posts by Gregory C. Guest (see all)
- DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil - November 22, 2017
- HYBRiD-XL Launch NEWS: DRG is expanding the test menu with TM-CA 72-4! - November 8, 2017
- DRG´s Newly Optimized Salivary Testosterone Kit used in New Study! - September 18, 2017
News and Updates
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...read more
We are proud to announce the launch of a new assays for DRG:HYBRiD-XL®: TM-CA 72-4. Clinical Application: Tumor Marker (gastrointestinal cancer) Tumor Marker (ovarian cancer) CA 72‑4 is the marker of choice for the therapeutic monitoring and follow-up...read more
New Poster presented using DRG´s newly optimized Salivary Testosterone Kit Ellie Shuo Jin, Doctoral Candidate in Clinical Psychology of the University of Texas at Austin, presented her poster at the Meeting of International Society of Psychoneuroendocrinology...read more
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG Group...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference tracks and...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more